MiR-34b/c rs4938723 Polymorphism Significantly Decreases the Risk of Digestive Tract Cancer: Meta-analysis |
Ji, Tian-Xing
(Department of Clinical Laboratory, the Second Affiliated Hospital of Guangzhou Medical University)
Zhi, Cheng (Department of Clinical Pathology, the Second Affiliated Hospital of Guangzhou Medical University) Guo, Xue-Guang (Department of Clinical Laboratory, the Third Affiliated Hospital of Guangzhou Medical University) Zhou, Qiang (Department of Clinical Laboratory, the Second Affiliated Hospital of Guangzhou Medical University) Wang, Guo-Qiang (Department of Gastrointestinal Surgery, Lab of Surgery, the Second Affiliated Hospital of Guangzhou Medical University) Chen, Bo (Department of Clinical Laboratory, the Second Affiliated Hospital of Guangzhou Medical University) Ma, Fei-Fei (Department of VIP Obstetrics, the Second Affiliated Hospital of Guangzhou Medical University) |
1 | Corney DC, Flesken-Nikitin A, Godwin AK, et al (2007). MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesionindependent growth. Cancer Res, 67, 8433-8. DOI |
2 | Corney DC, Hwang CI, Matoso A, et al (2010). Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res, 16, 1119-28. DOI |
3 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI |
4 | Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI |
5 | Gao LB, Li LJ, Pan XM, et al (2013). A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer. Biol Chem, 394, 415-20. |
6 | Han Y, Pu R, Han X, et al (2013). Associations of pri-miR- 34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk. PLoS One, 8, 58564. DOI |
7 | He L, He X, Lim LP, et al (2007). A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-4. DOI |
8 | Kalimutho M, Di Cecilia S, Del Vecchio Blanco G, et al (2011). Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer. Br J Cancer, 104, 1770-8. DOI |
9 | Li L, Wu J, Sima X, et al (2013). Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumour Biol, 34, 1919-23. DOI |
10 | Lujambio A, Calin GA, Villanueva A, et al (2008). A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A, 105, 13556-61. DOI |
11 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
12 | Normand SL (1999). Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med, 18, 321-59. DOI |
13 | Oh J, Kim JW, Lee BE, et al (2014). Polymorphisms of the primiR- 34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer. Oncol Rep, 31, 995-1002. |
14 | Pan XM, Sun RF, Li ZH, et al (2015). Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer. Genet Test Mol Biomarkers. |
15 | Son MS, Jang MJ, Jeon YJ, et al (2013). Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma. Gene, 524, 156-60. DOI |
16 | Suzuki H, Yamamoto E, Nojima M, et al (2010). Methylationassociated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis, 31, 2066-73. DOI |
17 | Suzuki R, Yamamoto E, Nojima M, et al (2014). Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk. J Gastroenterol, 49, 1135-44. DOI |
18 | Tao T, Chen S, Xu B, et al (2014). Association between hsamiR- 34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls. Chin J Cancer Res, 26, 315-22. |
19 | Tian Q, Jia J, Ling S, et al (2014). A causal role for circulating miR-34b in osteosarcoma. Eur J Surg Oncol, 40, 67-72. DOI |
20 | Toyota M, Suzuki H, Sasaki Y, et al (2008). Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res, 68, 4123-32. DOI |
21 | Vogt M, Munding J, Gruner M, et al (2011). Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch, 458, 313-22. DOI |
22 | Wang LQ, Kwong YL, Wong KF, et al (2014). Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia. J Transl Med, 12, 52. DOI |
23 | Wang Z, Wu J, Zhang G, et al (2013). Associations of miR- 499 and miR-34b/c polymorphisms with susceptibility to hepatocellular carcinoma: an evidence-based evaluation. Gastroenterol Res Pract, 2013, 719202. |
24 | Xu Y, Liu L, Liu J, et al (2011). A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer, 128, 412-7. DOI |
25 | Xue W, Zhu M, Wang Y, et al (2015). Association between PLCE1 rs2274223 A > G polymorphism and cancer risk: proof from a meta-analysis. Sci Rep, 5, 7986. DOI |
26 | Yang C, Ma X, Liu D, et al (2014). Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population. Tumour Biol, 35, 12545-54. DOI |
27 | Yi DH, Wang BG, Zhong XP, et al (2014). Pri-miR-34b/c rs4938723 TC heterozygote is associated with increased cancer risks: evidence from published data. Tumour Biol, 35, 11967-75. DOI |
28 | Yin J, Wang X, Zheng L, et al (2013). Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population. PLoS One, 8, 80570. DOI |
29 | Zhang J, Huang X, Xiao J, et al (2014a). Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations. PLoS One, 9, 100055. DOI |
30 | Zhang S, Qian J, Cao Q, et al (2014b). A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population. Mutagenesis, 29, 149-54. DOI |
31 | Chen X, Hu H, Guan X, et al (2012). CpG island methylation status of miRNAs in esophageal squamous cell carcinoma. Int J Cancer, 130, 1607-13. DOI |
32 | Bensen JT, Tse CK, Nyante SJ, et al (2013). Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the carolina breast cancer study. Cancer Causes Control, 24, 1099-109. DOI |
![]() |